Fig. 2From: A phase Ib study of capecitabine and ziv-aflibercept followed by a phase II single-arm expansion cohort in chemotherapy refractory metastatic colorectal cancerKaplan-Meier curves for (a) progression free survival and (b) overall survivalBack to article page